Form 8-K - Current report:
SEC Accession No. 0001193125-24-003489
Filing Date
2024-01-05
Accepted
2024-01-05 17:23:31
Documents
17
Period of Report
2024-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d149661d8k.htm   iXBRL 8-K 32652
2 EX-1.1 d149661dex11.htm EX-1.1 193903
3 EX-5.1 d149661dex51.htm EX-5.1 11718
4 EX-99.1 d149661dex991.htm EX-99.1 8517
5 EX-99.2 d149661dex992.htm EX-99.2 8671
9 GRAPHIC g149661g0106000430491.jpg GRAPHIC 2142
  Complete submission text file 0001193125-24-003489.txt   448318

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cprx-20240104.xsd EX-101.SCH 2870
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20240104_lab.xml EX-101.LAB 17993
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20240104_pre.xml EX-101.PRE 11274
11 EXTRACTED XBRL INSTANCE DOCUMENT d149661d8k_htm.xml XML 3412
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 24517565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)